Publicaciones en las que colabora con Borja Sáez Ochoa (12)

2023

  1. In vivo screening characterizes chromatin factor functions during normal and malignant hematopoiesis

    Nature Genetics, Vol. 55, Núm. 9, pp. 1542-1554

2008

  1. Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth

    Molecular Cancer Research, Vol. 6, Núm. 12, pp. 1830-1840

2007

  1. Multicolor interphase cytogenetics for the study of plasma cell dyscrasias

    Oncology Reports, Vol. 18, Núm. 5, pp. 1099-1106

  2. Multiple myeloma primary cells show a highly rearranged unbalanced genome with amplifications and homozygous deletions irrespective of the presence of immunoglobulin-related chromosome translocations

    Haematologica, Vol. 92, Núm. 6, pp. 795-802

  3. Simultaneous translocations of FGFR3/MMSET and CCND1 into two different IGH alleles in multiple myeloma: lack of concurrent activation of both proto-oncogenes

    Cancer Genetics and Cytogenetics, Vol. 175, Núm. 1, pp. 65.e1-65.e5

2006

  1. Identification of overexpressed genes in frequently gained/amplified chromosome regions in multiple myeloma

    Haematologica, Vol. 91, Núm. 2, pp. 184-191

  2. Identification of recurrent chromosomal breakpoints in multiple myeloma with complex karyotypes by combined G-banding, spectral karyotyping, and fluorescence in situ hybridization analyses

    Cancer Genetics and Cytogenetics, Vol. 169, Núm. 2, pp. 143-149

  3. Interphase FISH for the detection of breakpoints in IG loci and chromosomal changes with adverse prognostic impact in multiple myeloma with normal karyotypes

    Cancer Genetics and Cytogenetics

  4. Molecular cytogenetic characterization of chromosomal changes in multiple myeloma new insights into pathogenesis and diagnosis

    Molecular cytogenetic characterization of chromosomal changes in multiple myeloma new insights into pathogenesis and diagnosis

2005

  1. Amplification of IGH/MYC fusion in clinically aggressive IGH/BCL2-positive germinal center B-cell lymphomas

    Genes Chromosomes and Cancer, Vol. 43, Núm. 4, pp. 414-423

  2. Erratum: NUP98 is fused to HOXA9 in a variant complex t(7;11;13;17) in a patient with AML-M2 (Cancer Genetics and Cytogenetics (2005) 157 (151-6))

    Cancer Genetics and Cytogenetics

  3. NUP98 is fused to HOXA9 in a variant complex t(7;11;13;17) in a patient with AML-M2

    Cancer Genetics and Cytogenetics, Vol. 157, Núm. 2, pp. 151-156